In This Article:
We came across a bullish thesis on CVS Health Corporation (CVS) on Substack by Hidden Market Gems. In this article, we will summarize the bulls’ thesis on CVS. CVS Health Corporation (CVS)'s share was trading at $70.18 as of April 9th. CVS’s trailing and forward P/E were 19.17 and 11.93 respectively according to Yahoo Finance.
Iakov Filimonov/Shutterstock.com
When markets start to crack under the weight of tariffs, inflation, and geopolitical uncertainty, the smartest strategy isn’t chasing headlines — it’s backing companies that hold steady. CVS Health (CVS) is exactly that kind of name. With 95% of its revenue generated within the U.S., it stands comfortably outside the reach of global trade tensions. It operates in essentials — retail and pharmacy — the kind of products people continue to buy regardless of economic conditions. The company has already gone through a restructuring, emerging with leaner operations and strong, consistent cash flow. That’s the story. No hype, no tangled global logistics, and no vulnerability to trade war noise. CVS has already climbed over 40% this year, and there’s still room for more. If the market is set to tumble because of tariff concerns, CVS is the type of stock that stays grounded — reliable, essential, and built to perform in such an environment.
CVS Health Corporation (CVS) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 74 hedge fund portfolios held CVS at the end of the fourth quarter which was 63 in the previous quarter. While we acknowledge the risk and potential of CVS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than CVS but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.
Disclosure: None. This article was originally published at Insider Monkey.